Spark Biomedical News

Long-Term Addiction Clinical TrialRead MoreRead More
Spark Biomedical, Inc Enlists Expertise of Eric Hargan and The Hargan GroupRead MoreRead More
Finalists Announced: The Innovation Awards 2022Read MoreRead More
FinPay & Spark Biomedical PartnershipRead MoreRead More
Sierra Tucson Combats Opioid Withdrawal Using Groundbreaking Wearable Neurostimulation TherapyRead MoreRead More
Spark Biomedical Deepens Behavioral Health & Neurostimulation Expertise with Two Key HiresRead MoreRead More
Dallas-Based Spark Biomedical Gets FDA Clearance for its Drug‑Free Solution to Opioid WithdrawalRead MoreRead More
Bux Pain Management Treats First Commercial Patient in the Nation Using Spark Biomedical’s Sparrow Therapy SystemRead MoreRead More
Spark Biomedical’s Sparrow Therapy System™ receives FDA Clearance for Opioid Withdrawal Relief in AdultsRead MoreRead More
Spark Biomedical Receives FDA Breakthrough Device Designation for Infant Transcutaneous Auricular Neurostimulation (tAN™) Device, The Roo™ SystemRead MoreRead More